Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Assets: 2020-2024

Historic Assets for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to $1.1 billion.

  • Janux Therapeutics' Assets rose 47.44% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 47.44%. This contributed to the annual value of $1.1 billion for FY2024, which is 179.05% up from last year.
  • Per Janux Therapeutics' latest filing, its Assets stood at $1.1 billion for FY2024, which was up 179.05% from $380.4 million recorded in FY2023.
  • Janux Therapeutics' 5-year Assets high stood at $1.1 billion for FY2024, and its period low was $16.2 million during FY2020.
  • In the last 3 years, Janux Therapeutics' Assets had a median value of $380.4 million in 2023 and averaged $602.0 million.
  • Per our database at Business Quant, Janux Therapeutics' Assets soared by 2,242.13% in 2021 and then dropped by 4.16% in 2022.
  • Yearly analysis of 5 years shows Janux Therapeutics' Assets stood at $16.2 million in 2020, then skyrocketed by 2,242.13% to $379.8 million in 2021, then dropped by 4.16% to $364.0 million in 2022, then climbed by 4.50% to $380.4 million in 2023, then surged by 179.05% to $1.1 billion in 2024.